DrugPatentWatch Database Preview
Details for Patent: 10,226,423
Try a free trial
See Plans and Pricing
Which drugs does patent 10,226,423 protect, and when does it expire?
Patent 10,226,423 protects GLOPERBA and is included in one NDA.
Summary for Patent: 10,226,423
| Title: | Colchicine drug-to-drug interactions |
| Abstract: | The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided. |
| Inventor(s): | Muni; Indu (North Reading, MA), Vishnupad; Naomi (Reading, MA) |
| Assignee: | RxOMEG Therapeutics LLC (Woburn, MA) |
| Application Number: | 15/848,498 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,226,423
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Romeg Theraps Llc | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
